Homecrowd sourcedAeris Biotechnologies on Dalmore Group 2022

Aeris Biotechnologies on Dalmore Group 2022

[ad_1]

Analytics

Security Type

Equity – Common

Industry

Healthcare & Pharmaceuticals

Aeris Biotechnologies is raising funds through Reg A+ crowdfunding with Dalmore Group as the Broker-Dealer. The company is bringing an innovative and green approach to the treatment of asthma. The business has developed a first-of-its-kind, in-home, and affordable treatment kit to control the dust mites and associated allergens that cause asthma. The technology of Aeris Biotechnologies is green, scalable, and patent-protected. Aaron Michael Gunn and Dr. David Richard Harper founded Aeris Biotechnologies in 2021. The current crowdfunding campaign has a maximum target of $15,000,000. The campaign proceeds will be used for business development, marketing, research and development, product development, and working capital.

Balance Sheet

Cash and Cash Equivalents

$33,242

Total Assets

$33,242

Accounts Payable & Accrued Liabilities

$104,548

Long Term Debt

$50,000

Total Liabilities

$104,548

Total Stockholders’ Equity

$-71,306

Total Liabilities and Equity

$33,242

Statement of Comprehensive Income Information

Earnings Per Share – Basic

$0.00

Earnings Per Share – Diluted

$0.00

Auditor: BF Borgers CPA PC

Financials as of: 07/26/2022

Create a free account today to gain access to KingsCrowd analytics.

Pay Monthly


Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd’s quantitative ratings on all raises.
Plan Includes:

Everything in Free, plus
Company specific “>
KingsCrowd ratings (excluding risk)
Advanced company search (
with ratings)
“>
Markets page filters and historical industry data

Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd’s qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed “>
Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)

Search and filter based on Analyst Reports
In-depth risk ratings for every raise

Get Edge Pro Annual

Analyst Report Analyst Report Methodology Article

Thank you for your vote on Aeris Biotechnologies on Dalmore Group 2022

Thank you for your vote on Aeris Biotechnologies on Dalmore Group 2022



[ad_2]

RELATED ARTICLES

Most Popular

Recent Comments